Callan Capital’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$7.08M Sell
26,755
-402
-1% -$107K 0.52% 36
2024
Q4
$6.89M Buy
27,157
+55
+0.2% +$14.8K 0.5% 40
2024
Q3
$7.65M Sell
27,102
-927
-3% -$257K 0.53% 32
2024
Q2
$7.46M Sell
28,029
-601
-2% -$158K 0.61% 29
2024
Q1
$7.75M Sell
28,630
-769
-3% -$202K 0.68% 28
2023
Q4
$7.37M Sell
29,399
-6,568
-18% -$1.56M 0.7% 29
2023
Q3
$8.46M Buy
35,967
+3,159
+10% +$770K 0.91% 26
2023
Q2
$8.03M Buy
32,808
+1,761
+6% +$428K 0.89% 24
2023
Q1
$7.4M Buy
31,047
+1,319
+4% +$317K 0.86% 24
2022
Q4
$7.37M Sell
29,728
-98
-0.3% -$23.8K 0.91% 25
2022
Q3
$6.67M Sell
29,826
-2,365
-7% -$564K 1.09% 21
2022
Q2
$7.58M Buy
32,191
+207
+0.6% +$49.9K 1.17% 20
2022
Q1
$8.14M Buy
31,984
+3,017
+10% +$745K 1.12% 17
2021
Q4
$7.72M Buy
28,967
+1,488
+5% +$379K 1.12% 17
2021
Q3
$6.79M Buy
27,479
+2,575
+10% +$661K 1.13% 18
2021
Q2
$6.16M Buy
24,904
+1,493
+6% +$357K 1.07% 18
2021
Q1
$5.36M Buy
23,411
+3,623
+18% +$831K 0.97% 20
2020
Q4
$4.43M Buy
19,788
+2,122
+12% +$454K 0.9% 23
2020
Q3
$3.6M Buy
17,666
+4,524
+34% +$916K 0.81% 25
2020
Q2
$2.53M Sell
13,142
-1,056
-7% -$198K 0.63% 27
2020
Q1
$2.36M Sell
14,198
-2,023
-12% -$370K 0.73% 26
2019
Q4
$3.11M Buy
16,221
+1,024
+7% +$184K 0.85% 21
2019
Q3
$2.55M Sell
15,197
-362
-2% -$62K 0.73% 23
2019
Q2
$2.71M Buy
15,559
+513
+3% +$86.6K 0.87% 22
2019
Q1
$2.6M Buy
15,046
+1,290
+9% +$219K 0.85% 22
2018
Q4
$2.21M Buy
13,756
+1,566
+13% +$265K 0.8% 21
2018
Q3
$2.2M Buy
12,190
+687
+6% +$118K 0.73% 21
2018
Q2
$1.83M Buy
11,503
+2,119
+23% +$334K 0.63% 23
2018
Q1
$1.44M Buy
9,384
+3,830
+69% +$611K 0.47% 27
2017
Q4
$856K Buy
5,554
+303
+6% +$46.5K 0.3% 34
2017
Q3
$800K Buy
5,251
+1,779
+51% +$265K 0.3% 34
2017
Q2
$512K Sell
3,472
-87
-2% -$12.3K 0.19% 36
2017
Q1
$491K Buy
+3,559
New +$479K 0.2% 33

Other funds holding VHT

Callan Capital's VHT Position: Q1 2025 in Review

Callan Capital reduced its Vanguard Health Care ETF (VHT) stake by 1.5% in Q1 2025, selling an estimated $107K and leaving 26,755 shares worth $7.08M. The position accounts for 0.52% of the portfolio, ranked #36.

Callan Capital first reported a position in VHT in Q1 2017 and has held it in 33 quarters since. The position peaked at $8.46M in Q3 2023. 1,058 funds tracked by Wall St. Rank hold VHT as of Q1 2025.

  • Callan Capital held 26,755 shares of Vanguard Health Care ETF worth $7.08M as of Q1 2025.
  • Callan Capital sold 402 Vanguard Health Care ETF shares in Q1 2025, an estimated $107K.
  • Vanguard Health Care ETF made up 0.52% of Callan Capital's portfolio in Q1 2025, its #36 holding.
  • Callan Capital first reported a position in Vanguard Health Care ETF in Q1 2017 and has held it in 33 quarters since.
  • Callan Capital's Vanguard Health Care ETF position peaked at $8.46M in Q3 2023.
  • 1,058 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.